The future of cardiac repair: a review on cell-free nanotherapies for regenerative myocardial infarction
Drug Delivery and Translational Research · 2025-07 · 15 (7) · 2253-2271
DOI: 10.1007/s13346-024-01763-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Delivery and Translational Research, online erschienen am 20.01.2025. Verfasst von Nermeen H Kamal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Division of Pharmaceutical Sciences. College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport, A…. Hauptthemen laut MEDLINE: Myocardial Infarction, Regeneration, Nanoparticles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alexandria University.
Abstract (Originalsprache)
Cardiovascular diseases as myocardial infarction (MI) represent a major cause for morbidity and mortality worldwide. Even though, patients who survive MI are susceptible to high risk of heart failure. This is mainly attributed to the major loss of cardiomyocytes and limited regenerative potential of myocardium. Despite the availability of various cardiovascular drugs, they fail to address the main cause of MI. The optimum therapeutic goal should therefore focus on enhancing cardiac regeneration through cellular and cell-free therapeutic approaches. This review focused on different mechanisms of cardiac regeneration that can be achieved via non-cellular therapeutic modalities. Passive and active targeting of the infarcted myocardium using various nanoparticles that can be loaded with growth factors, drugs or affordable natural products can reduce negative ventricular remodeling, infarct size and the apoptotic rate of cardiomyocytes. In addition, injectable biomaterials-based nanocomposite can be used as a scaffold to support infarcted heart and recruit cells. Innovative affordable and less invasive cell-free approaches can be implemented to enhance cardiac regeneration post MI. Graphical abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, Division of Pharmaceutical Sciences. College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport, Alexandria, Egypt.
- Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, 1 Khartoum Square, Azarita, P.O. Box 21521, Alexandria, Egypt. lamia.heikal@alexu.edu.eg.
- Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, 1 Khartoum Square, Azarita, P.O. Box 21521, Alexandria, Egypt.
ORCID-Profile: Nermeen H Kamal, Lamia A Heikal, Ossama Y Abdallah
Förderung
- Alexandria University
Zitieren
APA
Kamal, N. H., Heikal, L. A., & Abdallah, O. Y. (2025). The future of cardiac repair: a review on cell-free nanotherapies for regenerative myocardial infarction. Drug Delivery and Translational Research, 15(7), 2253-2271. https://doi.org/10.1007/s13346-024-01763-y
Vancouver
Kamal NH, Heikal LA, Abdallah OY. The future of cardiac repair: a review on cell-free nanotherapies for regenerative myocardial infarction. Drug Delivery and Translational Research. 2025;15(7):2253-2271. doi:10.1007/s13346-024-01763-y
BibTeX
@article{Kamal2025,
author = {Kamal, Nermeen H and Heikal, Lamia A and Abdallah, Ossama Y},
title = {The future of cardiac repair: a review on cell-free nanotherapies for regenerative myocardial infarction},
journal = {Drug Delivery and Translational Research},
year = {2025},
volume = {15},
number = {7},
pages = {2253--2271},
doi = {10.1007/s13346-024-01763-y}
}
EUVIMED